Industries Market Research Reports

Subscribe to RSS Feed
  1. 15 Oct 2024  |  Global  |  Technology Research

    Emerging Non-opioid Treatments for Pain Management

    Advances in Non-opioid Therapies for Neuropathic, Migraine, and Cancer Pain Management Unlock New Growth Opportunities

    The analysis explores cutting-edge advancements in non-opioid medications by delving into their mechanisms of action at a molecular scale, scrutinizing results from current clinical research initiatives, and appraising preparedness for and plausibility of regulatory approval. The considerations aim to highlight how these treatments may offer viable...

    $4,950.00
  2. 25 Jul 2024  |  Global  |  Technology Research

    Engineered Antibody Therapeutics for Cancer

    Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies

    This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...

    $4,950.00
  3. 24 Jul 2024  |  Global  |  Technology Research

    Menopause Care Management Technology Growth Opportunities, 2024 2029

    Growing competitive intensity fuels future growth potential in menopause care management

    As the global population ages, more attention should be paid to the needs of individuals aged 45 to 55, particularly women in the perimenopausal and menopausal stages. Women aged 45 and above are at a crucial stage in terms of professional and personal responsibilities; however, they are challenged by menopausal symptoms, such as hot flashes, sleep...

    $4,950.00
  4. 25 Jun 2024  |  Global  |  Market Research

    Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024 2029

    Risk-sharing Business Models for Next-generation Biologics Will Drive Bio-CDMO Growth and Spur Future Potential

    By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

    $4,950.00
  5. 14 Jun 2024  |  Global  |  Market Research

    Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028

    GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth

    Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...

    $4,950.00
  6. 28 Nov 2023  |  Global  |  Technology Research

    Growth Opportunities in Obesity Drugs and Delivery Platforms

    GLP-1-based Drugs, Along With Injector and Nanomaterial Delivery Platforms, Drive Transformational Industry Growth

    The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...

    $4,950.00
  7. 10 May 2023  |  Global  |  Market Research

    Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector

    Value Chain Expansion to Support Next generation Biologics Drives Future Growth Potential

    This research service provides an overview of the global biologics contract development and manufacturing organization (bio-CDMO) market and a 6-year market revenue forecast (2023 to 2028). The geographic scope covers three key regions, namely North America (NA); Europe; and Asia-Pacific (APAC). The report offers a detailed segment analysis of...

    $4,950.00

    Special Price $4,455.00 save 10 %

  8. 03 Feb 2023  |  North America  |  Market Research

    Global Pharmaceutical Continuous Manufacturing Market, Growth Opportunities

    Regulatory Acceptance Propelling Continuous Manufacturing Investments through Partnerships and In-house Expansions

    Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...

    $4,950.00

    Special Price $4,207.50 save 15 %

  9. 30 Dec 2022  |  Global  |  Market Research

    Growth Opportunities in Global Pharmaceutical Logistics

    Cold chain Investments and Hybrid Clinical Trials to Ensure Transformational Growth of Pharmaceutical Logistics

    Medicine production supply chains are currently operating under huge stress due to the war in Ukraine, COVID-19-related disruptions, logistics bottlenecks, and inflation. An energy-related shutdown of production would have a detrimental effect on the supply of critical medicines to patients in the EU and worldwide. The excessive amount of pressure ...

    $2,450.00

    Special Price $2,082.50 save 15 %

  10. 20 Dec 2022  |  Global  |  Technology Research

    Advances and Growth Opportunities in RNA Vaccines

    Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines

    RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...

    $4,950.00

    Special Price $4,207.50 save 15 %